BAMF
ONC

BI Asset Management Fondsmaeglerselskab’s BeOne Medicines Ltd ONC Stock Holding History

BI Asset Management Fondsmaeglerselskab’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,012
Closed -$183K – 799
2023
Q4 		$183K Buy
+1,012
New +$183K ﹤0.01% 661
2023
Q2 		– Sell
-1,287
Closed -$277K – 804
2023
Q1 		$277K Buy
+1,287
New +$309K 0.01% 540

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $14.3B AUM 34.19% 1-Year Est. Return

BI Asset Management Fondsmaeglerselskab's ONC Position: Q1 2024 in Review

BI Asset Management Fondsmaeglerselskab sold out of BeOne Medicines Ltd (ONC) in Q1 2024, closing a stake of 1,012 shares — an estimated $183K sold.

BI Asset Management Fondsmaeglerselskab first reported a position in ONC in Q1 2023 and held it in 2 quarters. The position peaked at $277K in Q1 2023. 205 funds tracked by Wall St. Rank hold ONC as of Q1 2024.

  • BI Asset Management Fondsmaeglerselskab reported no remaining BeOne Medicines Ltd position as of Q1 2024 after selling out during the quarter.
  • BI Asset Management Fondsmaeglerselskab sold 1,012 BeOne Medicines Ltd shares in Q1 2024, an estimated $183K.
  • BI Asset Management Fondsmaeglerselskab first reported a position in BeOne Medicines Ltd in Q1 2023 and held it in 2 quarters.
  • BI Asset Management Fondsmaeglerselskab's BeOne Medicines Ltd position peaked at $277K in Q1 2023.
  • 205 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2024.

Based on BI Asset Management Fondsmaeglerselskab's 13F filing for Q1 2024, filed 3 May 2024.